Objective:

To outline the requirements and considerations for referring patients for corneal cross-linking (CXL) in the context of specialty contact lens prescribing.

Approach:

Key Findings:

• CXL is essential for preventing corneal distortion in keratoconus and ectasia.
• Insurance coverage for CXL requires thorough documentation of medical necessity.
• Patients must meet specific clinical criteria, including age, visual acuity, and corneal thickness.

Interpretation:

Practitioners must ensure they have a solid diagnosis and meet all criteria before referring patients for CXL to facilitate insurance coverage.

Limitations:

• Variability in insurance policies may lead to coverage gaps.
• Additional contraindications may limit patient eligibility for CXL.

Conclusion:

Practitioners should prepare comprehensive documentation and discuss potential insurance issues with patients before referring for CXL.

Sources:

• Global Delphi Panel on Keratoconus
• Glaukos
• Medicare Coverage Definition
• Anthem Clinical Guidelines
• United Healthcare Policy
• American Academy of Ophthalmology EyeWiki
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.